Skip to content

Epoetin theta

Biopoin, Eporatio (epoetin theta) is a protein pharmaceutical. Epoetin theta was first approved as Biopoin on 2009-10-23. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms.
Trade Name Biopoin, Eporatio
Common Name Epoetin theta
Indication anemia, chronic kidney failure, neoplasms
Drug Class Erythropoietins
Epoetin theta
Get full access now